 | • レポートコード：MRC2012B1470 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ウィルソン病の世界市場を広く調査・分析し、今後の市場展望をまとめております。ウィルソン病の種類別市場規模（トリエンチン、ペニシラミン、その他）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bausch Health、Tsumura、Univar Solutions、Teva、APOTEX、Endo International、Taj Pharmaceutical、ANI Pharmaceuticals、MSN Laboratories、Sinepharm、Kadmon Holdings、 ・地域別グローバル市場分析 2015年-2020年 ・ウィルソン病の北米市場（アメリカ、カナダ、メキシコ） ・ウィルソン病のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ウィルソン病のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ウィルソン病の南米市場（ブラジル、アルゼンチン） ・ウィルソン病の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：トリエンチン、ペニシラミン、その他 ・用途別分析：病院、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Wilson’s Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Wilson’s Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 237 million by 2025, from USD 202.7 million in 2019.
Market segmentation
Wilson’s Disease market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Wilson’s Disease market has been segmented into:
Trientine
Penicillamine
Others
By Application, Wilson’s Disease has been segmented into:
Hospital
Drugs Stores
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Wilson’s Disease market presented in the report. This section sheds light on the sales growth of different regional and country-level Wilson’s Disease markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Wilson’s Disease market.
The report offers in-depth assessment of the growth and other aspects of the Wilson’s Disease market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Wilson’s Disease Market Share Analysis
Wilson’s Disease competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Wilson’s Disease sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Wilson’s Disease sales, revenue and market share for each player covered in this report.
The major players covered in Wilson’s Disease are:
Bausch Health
Tsumura
Univar Solutions
Teva
APOTEX
Endo International
Taj Pharmaceutical
ANI Pharmaceuticals
MSN Laboratories
Sinepharm
Kadmon Holdings
Among other players domestic and global, Wilson’s Disease market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Wilson’s Disease Market Overview
1.1 Product Overview and Scope of Wilson’s Disease
1.2 Classification of Wilson’s Disease by Type
1.2.1 Global Wilson’s Disease Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Wilson’s Disease Revenue Market Share by Type in 2019
1.2.3 Trientine
1.2.4 Penicillamine
1.2.5 Others
1.3 Global Wilson’s Disease Market by Application
1.3.1 Overview: Global Wilson’s Disease Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Others
1.4 Global Wilson’s Disease Market by Regions
1.4.1 Global Wilson’s Disease Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Wilson’s Disease (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Wilson’s Disease Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Wilson’s Disease Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Wilson’s Disease Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Wilson’s Disease Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Wilson’s Disease Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bausch Health
2.1.1 Bausch Health Details
2.1.2 Bausch Health Major Business
2.1.3 Bausch Health SWOT Analysis
2.1.4 Bausch Health Product and Services
2.1.5 Bausch Health Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.2 Tsumura
2.2.1 Tsumura Details
2.2.2 Tsumura Major Business
2.2.3 Tsumura SWOT Analysis
2.2.4 Tsumura Product and Services
2.2.5 Tsumura Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.3 Univar Solutions
2.3.1 Univar Solutions Details
2.3.2 Univar Solutions Major Business
2.3.3 Univar Solutions SWOT Analysis
2.3.4 Univar Solutions Product and Services
2.3.5 Univar Solutions Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.5 APOTEX
2.5.1 APOTEX Details
2.5.2 APOTEX Major Business
2.5.3 APOTEX SWOT Analysis
2.5.4 APOTEX Product and Services
2.5.5 APOTEX Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.6 Endo International
2.6.1 Endo International Details
2.6.2 Endo International Major Business
2.6.3 Endo International Product and Services
2.6.4 Endo International Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.7 Taj Pharmaceutical
2.7.1 Taj Pharmaceutical Details
2.7.2 Taj Pharmaceutical Major Business
2.7.3 Taj Pharmaceutical Product and Services
2.7.4 Taj Pharmaceutical Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.8 ANI Pharmaceuticals
2.8.1 ANI Pharmaceuticals Details
2.8.2 ANI Pharmaceuticals Major Business
2.8.3 ANI Pharmaceuticals Product and Services
2.8.4 ANI Pharmaceuticals Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.9 MSN Laboratories
2.9.1 MSN Laboratories Details
2.9.2 MSN Laboratories Major Business
2.9.3 MSN Laboratories Product and Services
2.9.4 MSN Laboratories Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sinepharm
2.10.1 Sinepharm Details
2.10.2 Sinepharm Major Business
2.10.3 Sinepharm Product and Services
2.10.4 Sinepharm Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
2.11 Kadmon Holdings
2.11.1 Kadmon Holdings Details
2.11.2 Kadmon Holdings Major Business
2.11.3 Kadmon Holdings Product and Services
2.11.4 Kadmon Holdings Wilson’s Disease Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Wilson’s Disease Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Wilson’s Disease Players Market Share
3.2.2 Top 10 Wilson’s Disease Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Wilson’s Disease Revenue and Market Share by Regions
4.2 North America Wilson’s Disease Revenue and Growth Rate (2015-2020)
4.3 Europe Wilson’s Disease Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Wilson’s Disease Revenue and Growth Rate (2015-2020)
4.5 South America Wilson’s Disease Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Wilson’s Disease Revenue and Growth Rate (2015-2020)
5 North America Wilson’s Disease Revenue by Countries
5.1 North America Wilson’s Disease Revenue by Countries (2015-2020)
5.2 USA Wilson’s Disease Revenue and Growth Rate (2015-2020)
5.3 Canada Wilson’s Disease Revenue and Growth Rate (2015-2020)
5.4 Mexico Wilson’s Disease Revenue and Growth Rate (2015-2020)
6 Europe Wilson’s Disease Revenue by Countries
6.1 Europe Wilson’s Disease Revenue by Countries (2015-2020)
6.2 Germany Wilson’s Disease Revenue and Growth Rate (2015-2020)
6.3 UK Wilson’s Disease Revenue and Growth Rate (2015-2020)
6.4 France Wilson’s Disease Revenue and Growth Rate (2015-2020)
6.5 Russia Wilson’s Disease Revenue and Growth Rate (2015-2020)
6.6 Italy Wilson’s Disease Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Wilson’s Disease Revenue by Regions
7.1 Asia-Pacific Wilson’s Disease Revenue by Regions (2015-2020)
7.2 China Wilson’s Disease Revenue and Growth Rate (2015-2020)
7.3 Japan Wilson’s Disease Revenue and Growth Rate (2015-2020)
7.4 Korea Wilson’s Disease Revenue and Growth Rate (2015-2020)
7.5 India Wilson’s Disease Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Wilson’s Disease Revenue and Growth Rate (2015-2020)
8 South America Wilson’s Disease Revenue by Countries
8.1 South America Wilson’s Disease Revenue by Countries (2015-2020)
8.2 Brazil Wilson’s Disease Revenue and Growth Rate (2015-2020)
8.3 Argentina Wilson’s Disease Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Wilson’s Disease by Countries
9.1 Middle East & Africa Wilson’s Disease Revenue by Countries (2015-2020)
9.2 Saudi Arabia Wilson’s Disease Revenue and Growth Rate (2015-2020)
9.3 UAE Wilson’s Disease Revenue and Growth Rate (2015-2020)
9.4 Egypt Wilson’s Disease Revenue and Growth Rate (2015-2020)
9.5 South Africa Wilson’s Disease Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Wilson’s Disease Revenue and Market Share by Type (2015-2020)
10.2 Global Wilson’s Disease Market Forecast by Type (2019-2024)
10.3 Trientine Revenue Growth Rate (2015-2025)
10.4 Penicillamine Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Wilson’s Disease Market Segment by Application
11.1 Global Wilson’s Disease Revenue Market Share by Application (2015-2020)
11.2 Wilson’s Disease Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Drugs Stores Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Wilson’s Disease Market Size Forecast (2021-2025)
12.1 Global Wilson’s Disease Market Size Forecast (2021-2025)
12.2 Global Wilson’s Disease Market Forecast by Regions (2021-2025)
12.3 North America Wilson’s Disease Revenue Market Forecast (2021-2025)
12.4 Europe Wilson’s Disease Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Wilson’s Disease Revenue Market Forecast (2021-2025)
12.6 South America Wilson’s Disease Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Wilson’s Disease Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Wilson's Disease Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Wilson's Disease by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Wilson's Disease Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Wilson's Disease Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Wilson's Disease Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Bausch Health Corporate Information, Location and Competitors
Table 7. Bausch Health Wilson's Disease Major Business
Table 8. Bausch Health Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 9. Bausch Health SWOT Analysis
Table 10. Bausch Health Wilson's Disease Product and Solutions
Table 11. Bausch Health Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Tsumura Corporate Information, Location and Competitors
Table 13. Tsumura Wilson's Disease Major Business
Table 14. Tsumura Wilson's Disease Total Revenue (USD Million) (2018-2019)
Table 15. Tsumura SWOT Analysis
Table 16. Tsumura Wilson's Disease Product and Solutions
Table 17. Tsumura Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Univar Solutions Corporate Information, Location and Competitors
Table 19. Univar Solutions Wilson's Disease Major Business
Table 20. Univar Solutions Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 21. Univar Solutions SWOT Analysis
Table 22. Univar Solutions Wilson's Disease Product and Solutions
Table 23. Univar Solutions Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Teva Corporate Information, Location and Competitors
Table 25. Teva Wilson's Disease Major Business
Table 26. Teva Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 27. Teva SWOT Analysis
Table 28. Teva Wilson's Disease Product and Solutions
Table 29. Teva Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. APOTEX Corporate Information, Location and Competitors
Table 31. APOTEX Wilson's Disease Major Business
Table 32. APOTEX Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 33. APOTEX SWOT Analysis
Table 34. APOTEX Wilson's Disease Product and Solutions
Table 35. APOTEX Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Endo International Corporate Information, Location and Competitors
Table 37. Endo International Wilson's Disease Major Business
Table 38. Endo International Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 39. Endo International SWOT Analysis
Table 40. Endo International Wilson's Disease Product and Solutions
Table 41. Endo International Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Taj Pharmaceutical Corporate Information, Location and Competitors
Table 43. Taj Pharmaceutical Wilson's Disease Major Business
Table 44. Taj Pharmaceutical Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 45. Taj Pharmaceutical SWOT Analysis
Table 46. Taj Pharmaceutical Wilson's Disease Product and Solutions
Table 47. Taj Pharmaceutical Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. ANI Pharmaceuticals Corporate Information, Location and Competitors
Table 49. ANI Pharmaceuticals Wilson's Disease Major Business
Table 50. ANI Pharmaceuticals Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 51. ANI Pharmaceuticals SWOT Analysis
Table 52. ANI Pharmaceuticals Wilson's Disease Product and Solutions
Table 53. ANI Pharmaceuticals Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. MSN Laboratories Corporate Information, Location and Competitors
Table 55. MSN Laboratories Wilson's Disease Major Business
Table 56. MSN Laboratories Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 57. MSN Laboratories SWOT Analysis
Table 58. MSN Laboratories Wilson's Disease Product and Solutions
Table 59. MSN Laboratories Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Sinepharm Corporate Information, Location and Competitors
Table 61. Sinepharm Wilson's Disease Major Business
Table 62. Sinepharm Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 63. Sinepharm SWOT Analysis
Table 64. Sinepharm Wilson's Disease Product and Solutions
Table 65. Sinepharm Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Kadmon Holdings Corporate Information, Location and Competitors
Table 67. Kadmon Holdings Wilson's Disease Major Business
Table 68. Kadmon Holdings Wilson's Disease Total Revenue (USD Million) (2017-2018)
Table 69. Kadmon Holdings SWOT Analysis
Table 70. Kadmon Holdings Wilson's Disease Product and Solutions
Table 71. Kadmon Holdings Wilson's Disease Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Global Wilson's Disease Revenue (Million USD) by Players (2015-2020)
Table 73. Global Wilson's Disease Revenue Share by Players (2015-2020)
Table 74. Global Wilson's Disease Revenue (Million USD) by Regions (2015-2020)
Table 75. Global Wilson's Disease Revenue Market Share by Regions (2015-2020)
Table 76. North America Wilson's Disease Revenue by Countries (2015-2020)
Table 77. North America Wilson's Disease Revenue Market Share by Countries (2015-2020)
Table 78. Europe Wilson's Disease Revenue (Million USD) by Countries (2015-2020)
Table 79. Asia-Pacific Wilson's Disease Revenue (Million USD) by Regions (2015-2020)
Table 80. South America Wilson's Disease Revenue by Countries (2015-2020)
Table 81. South America Wilson's Disease Revenue Market Share by Countries (2015-2020)
Table 82. Middle East and Africa Wilson's Disease Revenue (Million USD) by Countries (2015-2020)
Table 83. Middle East and Africa Wilson's Disease Revenue Market Share by Countries (2015-2020)
Table 84. Global Wilson's Disease Revenue (Million USD) by Type (2015-2020)
Table 85. Global Wilson's Disease Revenue Share by Type (2015-2020)
Table 86. Global Wilson's Disease Revenue Forecast by Type (2021-2025)
Table 87. Global Wilson's Disease Revenue by Application (2015-2020)
Table 88. Global Wilson's Disease Revenue Share by Application (2015-2020)
Table 89. Global Wilson's Disease Revenue Forecast by Application (2021-2025)
Table 90. Global Wilson's Disease Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Wilson's Disease Picture
Figure 2. Global Wilson's Disease Revenue Market Share by Type in 2019
Figure 3. Trientine Picture
Figure 4. Penicillamine Picture
Figure 5. Others Picture
Figure 6. Wilson's Disease Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Drugs Stores Picture
Figure 9. Others Picture
Figure 10. Global Wilson's Disease Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Wilson's Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Wilson's Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Wilson's Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Wilson's Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Wilson's Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Wilson's Disease Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Wilson's Disease Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Wilson's Disease Revenue Market Share in 2019
Figure 19. Global Top 10 Players Wilson's Disease Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Wilson's Disease Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Wilson's Disease Revenue Market Share by Regions (2015-2020)
Figure 23. Global Wilson's Disease Revenue Market Share by Regions in 2018
Figure 24. North America Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 25. Europe Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 27. South America Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 29. North America Wilson's Disease Revenue Market Share by Countries (2015-2020)
Figure 30. North America Wilson's Disease Revenue Market Share by Countries in 2019
Figure 31. USA Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 32. Canada Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 34. Europe Wilson's Disease Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Wilson's Disease Revenue Market Share by Countries in 2019
Figure 36. Germany Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 37. UK Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 38. France Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 39. Russia Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 40. Italy Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Wilson's Disease Revenue Market Share by Regions (2015-2020)
Figure 42. Asia-Pacific Wilson's Disease Revenue Market Share by Regions in 2019
Figure 43. China Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 44. Japan Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 45. Korea Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 46. India Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 48. South America Wilson's Disease Revenue Market Share by Countries (2015-2020)
Figure 49. South America Wilson's Disease Revenue Market Share by Countries in 2019
Figure 50. Brazil Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Wilson's Disease Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Wilson's Disease Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 55. UAE Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Wilson's Disease Revenue and Growth Rate (2015-2020)
Figure 58. Global Wilson's Disease Revenue Share by Type (2015-2020)
Figure 59. Global Wilson's Disease Revenue Share by Type in 2019
Figure 60. Global Wilson's Disease Market Share Forecast by Type (2021-2025)
Figure 61. Global Trientine Revenue Growth Rate (2015-2020)
Figure 62. Global Penicillamine Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Wilson's Disease Revenue Share by Application (2015-2020)
Figure 65. Global Wilson's Disease Revenue Share by Application in 2019
Figure 66. Global Wilson's Disease Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Revenue Growth Rate (2015-2020)
Figure 68. Global Drugs Stores Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Wilson's Disease Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Wilson's Disease Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Wilson's Disease Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Wilson's Disease Revenue Market Forecast (2021-2025)
Figure 74. Europe Wilson's Disease Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Wilson's Disease Revenue Market Forecast (2021-2025)
Figure 76. South America Wilson's Disease Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Wilson's Disease Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
ウィルソン病治療の世界市場（～2026年） Market Analysis and Insights: Global Wilson's Disease Treatment Market The global Wilson's Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Wilson's Disease Treatment Scope and Market Size Wilson's Dis…- ウィルソン病治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Wilson's Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wilson's Disease T…
- クラッベ病治療薬の世界市場（～2026年） Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…